This HTML5 document contains 193 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n11http://dx.doi.org/10.1136/
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35554016
rdf:type
wikibase:Item
schema:description
επιστημονικό άρθρο tudományos cikk գիտական հոդված scienca artikolo 2004年论文 scientific article published on April 2004 2004年论文 artikull shkencor 2004年論文 videnskabelig artikel artikel ilmiah научни чланак מאמר מדעי artigo científico wetenschappelijk artikel articol științific bilimsel makale 2004年論文 2004年论文 наукова стаття, опублікована у квітні 2004 teaduslik artikkel სამეცნიერო სტატია artigo científico bài báo khoa học 2004年の論文 мақолаи илмӣ научная статья мақолаи илмӣ 2004年论文 vetenskaplig artikel scientific article published on April 2004 vitskapeleg artikkel articolo scientifico 2004年论文 article scientific บทความทางวิทยาศาสตร์ 2004年論文 vědecký článek article scientifique artículu científicu espublizáu en 2004 artigo científico naučni članak artikulong pang-agham vitenskapelig artikkel 2004年論文 2004年论文 artykuł naukowy artículo científico publicado en 2004 mokslinis straipsnis এপ্রিল ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ wissenschaftlicher Artikel مقالة علمية نشرت في أبريل 2004 vedecký článok 2004 nî lūn-bûn article científic научна статия 2004年論文 2004년 논문 научни чланак scientific article published on April 2004 tieteellinen artikkeli
p:P577
wds:Q35554016-2261F2BB-57BC-433F-9740-1E5909506DBB
wdt:P577
2004-04-01T00:00:00Z
p:P407
wds:Q35554016-22858F80-AA48-4411-BEDA-B0E9BB410F91
wdt:P407
wd:Q1860
p:P2860
wds:Q35554016-CAE234EB-42F4-4AA8-AA94-9F98FCCBB56B wds:Q35554016-CC11FDE6-A2CB-4DC3-8C1C-FC88237896F8 wds:Q35554016-B89F47D5-064F-4193-91F6-CE06BD154485 wds:Q35554016-BD2A2212-6E1E-458E-AA5E-6995DA48A644 wds:Q35554016-BE896AE6-0AA4-44AA-BBFC-2D10BE70170B wds:Q35554016-9BD82559-E003-4747-870A-A7941D888549 wds:Q35554016-9E19405A-BB85-4E89-8FDE-86DE62ED07F6 wds:Q35554016-B4D7C511-7260-49E8-B066-1EE58DED6AF4 wds:Q35554016-8F6055E4-3809-4102-A4DC-986721C3CA9A wds:Q35554016-EB00051B-2345-432B-BBE9-53528BD177DB wds:Q35554016-F08B3E57-7A8E-4008-B37C-BA930A8F6FCA wds:Q35554016-F18377AB-628E-4FC0-AB79-DA297C22C7D9 wds:Q35554016-F5064DC9-D6E5-486E-8B5A-327019439D13 wds:Q35554016-3B74C8FD-781B-467D-BF01-6C5B624E3BEF wds:Q35554016-429EAEF3-940A-4658-9CA0-B286F59B184E wds:Q35554016-3278F417-6D65-4AA9-B68B-E1405264D308 wds:Q35554016-35B6DBF1-1502-4AAF-837B-596EF0BCC0B5 wds:Q35554016-3B60DD79-B519-4824-B8D2-36D752841598 wds:Q35554016-247E6744-99A1-43C4-BBBB-360F141038C7 wds:Q35554016-2F118C94-FCC3-4391-9043-66537C5A21C8 wds:Q35554016-2F192A6F-F8DB-4843-8418-4BE782E6DA73 wds:Q35554016-1D5609A9-579B-4D45-BA05-C301D98F7DFE wds:Q35554016-7B5B6F61-0807-4097-89EB-5C1ECEDB66F4 wds:Q35554016-7F578C59-627C-48F1-8612-9B216EA41541 wds:Q35554016-8198E119-80B8-4947-8188-45972AD5AD76 wds:Q35554016-833E6F9E-EB4B-405D-B829-262F9D70243A wds:Q35554016-71FA958C-7394-4A91-A8C5-925BFD96BDFD wds:Q35554016-7783F040-9F5F-4D16-B59A-6C1FC49EE014 wds:Q35554016-78F02D1E-A151-40A4-80C6-DD3DCFD7F3D9 wds:Q35554016-7910E276-AC0F-481A-B307-C6ABFA92E82D wds:Q35554016-60DEFE12-44A9-4D07-8789-BD341E65E206 wds:Q35554016-6644EEFA-499F-490C-BF53-05718068A51F wds:Q35554016-69C46E39-125F-40E1-BE80-E56B17C21CF6 wds:Q35554016-6B6094E4-D422-4A9A-8F04-C4532B82A5E4 wds:Q35554016-44A58EAC-99E3-4B67-A706-DC4A2B5CD600 wds:Q35554016-55349C3E-778B-4B24-8508-94E1DD1187D4 wds:Q35554016-5E837ED6-5C3A-4A51-AA90-6EDA94E3289F wds:Q35554016-19DAC4F3-4615-468E-BC2A-4C7C9B718FF5 wds:Q35554016-1C00AAAC-2C8C-4599-AECF-7B2C27E5C57A wds:Q35554016-0203F60F-839B-4174-A860-0CAA9694C1B2 wds:Q35554016-058B7C37-FB54-464E-ACDA-9C2AFA959B55
wdt:P2860
wd:Q58438667 wd:Q46497638 wd:Q73292550 wd:Q72069751 wd:Q34578517 wd:Q77406810 wd:Q67683062 wd:Q50674616 wd:Q37315567 wd:Q28375493 wd:Q26776972 wd:Q34772235 wd:Q50858766 wd:Q73619601 wd:Q34531168 wd:Q43792385 wd:Q52461317 wd:Q33731236 wd:Q33566405 wd:Q57006535 wd:Q73385957 wd:Q73782535 wd:Q41877219 wd:Q33843636 wd:Q36749296 wd:Q73532847 wd:Q39802766 wd:Q43817244 wd:Q73395340 wd:Q45279269 wd:Q27860872 wd:Q73304930 wd:Q70460533 wd:Q71459898 wd:Q70621382 wd:Q34254088 wd:Q35547301 wd:Q45879691 wd:Q43838182 wd:Q43837372 wd:Q34601733
p:P2093
wds:Q35554016-38CBB87E-0222-411D-BACA-B65732FE8EE3 wds:Q35554016-20DD985D-66D1-4C12-981D-65C694CB6913 wds:Q35554016-DBCF308F-177C-45C1-B133-4C6B5C07449D wds:Q35554016-95B7109F-8232-47A8-A83D-5A4A57006D44 wds:Q35554016-0BC0A955-737E-4BA6-BFC5-A649046D0D25
wdt:P2093
M J Banks N B Nixon P T Dawes L Goh D L Mattey
rdfs:label
Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease. Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease. Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease.
skos:prefLabel
Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease. Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease. Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease.
schema:name
Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease. Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease. Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease.
p:P50
wds:Q35554016-22E7B995-2200-4EFD-9DB6-8DFB35E8B588
wdt:P50
wd:Q37831495
p:P1476
wds:Q35554016-5D4C6C01-622D-4C9E-B759-EF216EDF8A1B
wdt:P1476
Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease
p:P304
wds:Q35554016-FCEDFBD3-72DC-4A2A-8EB2-8936141E4524
wdt:P304
420-425
p:P31
wds:Q35554016-ACF0B886-2C4D-453B-8F89-12873FBDED0E
wdt:P31
wd:Q13442814
p:P921
wds:Q35554016-BD476B4B-5B26-44FC-8EB7-C4B76B8B17E3
wdt:P921
wd:Q187255
p:P698
wds:Q35554016-95A67CF1-5347-4655-8EA5-AE8FA3D7E7E3
wdtn:P698
n12:15020337
wdt:P698
15020337
p:P1433
wds:Q35554016-1579ABE8-80E3-430C-984E-DD6D4D6867BC
wdt:P1433
wd:Q4767876
p:P433
wds:Q35554016-C83D52C3-68A7-4BE0-9164-04C83695DCB4
p:P478
wds:Q35554016-3C41F47A-90B0-4EA3-A141-D71D97CABBF6
wdt:P433
4
wdt:P478
63
p:P356
wds:Q35554016-8D6CEF0A-01C5-4192-A9D5-5E6E2B46485D
wdtn:P356
n11:ARD.2003.008011
wdt:P356
10.1136/ARD.2003.008011
p:P5875
wds:Q35554016-15B135B2-4559-4333-A729-089F96B3FDCD
wdt:P5875
277514634
p:P932
wds:Q35554016-3D486F88-98D3-4726-B0BE-5707C38651F3
wdt:P932
1754968